Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas.
| Autor: | Adarsh MB; Department of General Medicine, Government Medical College, Kasaragod, Kerala, India., Abraham A; Department of Community Medicine, Government Medical College, Kasaragod, Kerala, India., Kavitha P; Department of Anaesthesia, Government Medical College, Kasaragod, Kerala, India., Nandakumar MM; Department of ENT, Government Medical College, Kasaragod, Kerala, India., Vaman RS; Medical Superintendent, Government Medical College, Kasaragod, Kerala, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine [Indian J Crit Care Med] 2021 Apr; Vol. 25 (4), pp. 465-466. |
| DOI: | 10.5005/jp-journals-10071-23778 |
| Abstrakt: | Thrombocytopenia in coronavirus disease-2019 (COVID-19) can be attributed to multiple factors. Most often it is disease related. It is usually mild and if severe often associated with severe COVID-19 disease. It can also be due to drugs (Remdesivir, Tocilizumab) or coinfection with other viruses. Here we report two cases of severe thrombocytopenia in COVID-19 due to dengue coinfection. Most often the thrombocytopenia in dengue is self-resolving, and a careful "wait and watch" should suffice unlike COVID-19, where steroids can help if the cytopenia is due to cytokine storm or immune-mediated effects. How to Cite This Article: Adarsh MB, Abraham A, Kavitha P, Nandakumar MM, Vaman RS. Severe Thrombocytopenia in COVID-19: A Conundrum in Dengue-endemic Areas. Indian J Crit Care Med 2021;25(4):465-466. Competing Interests: Source of support: Nil Conflict of interest: None (Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|